What this consultation may focus on.
Confirming the pathology and stage information
Reviewing molecular and biomarker testing where relevant
Chemotherapy, immunotherapy and targeted-treatment planning
Treatment-response assessment
Supportive care for treatment-related symptoms
Decisions made from the whole clinical picture.
Lung cancer treatment depends on the exact type of cancer, stage, molecular features and overall health. For some patients, biomarker testing can identify treatment targets. A medical oncology plan may involve chemotherapy, immunotherapy, targeted therapy or combinations, often coordinated with surgery or radiation oncology.
Common reasons patients seek an oncology review.
- A lung biopsy or scan suggests or confirms cancer
- Molecular testing has been advised
- You need a systemic treatment plan after staging
- You are receiving treatment and need review of response or side effects
Questions patients often ask.
Why is molecular testing discussed in lung cancer?
Some lung cancers contain molecular changes that can be treated with specific targeted medicines. Testing is considered when it is relevant to the cancer type and stage.
Is immunotherapy used for lung cancer?
Immunotherapy is used in selected lung cancers, either alone or with other treatments. Suitability depends on the diagnosis, biomarkers, stage and clinical situation.
Do all lung cancers have the same treatment?
No. Small-cell and non-small-cell lung cancers are treated differently, and treatment also varies by stage and molecular profile.